Jan 27, 2012 · ... price of $21.51 and an average consensus analyst price target of $24.31. Pfizer Confirms FDA ... Duration: 0:55 Posted: Jan 27, 2012
May 23, 2024 · ... Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa ... DLO is risky and can go up 3X ... Duration: 0:27 Posted: May 23, 2024
Aug 8, 2023 · ... Inlyta and Xtandi. Its biosimilars portfolio is also expected to ... Stock price and valuation ... Duration: 0:15 Posted: Aug 8, 2023